ShumeiMengMDPhD
Endocrinology • Dallas, TXDivision Chief of Endocrinology, Baylor University Medical Center, Dallas
Dr. Meng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3500 Gaston Ave
Truett Suite 248A
Dallas, TX 75246Phone+1 214-820-6232Fax+1 214-820-6385
Summary
- My mission is to build an inpatient endocrine service that will provide excellent care to treat general endocrine diseases including diabetes, thyroid diseases, metabolic bone disease, and other rare endocrine conditions such as islet transplant and endocrine diseases in transplant patients. In addition, I would like to devote to medical education and commit to clinical research.
Education & Training
Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2010 - 2013
University of Mississippi Medical CenterResidency, Internal Medicine, 2007 - 2010
Certifications & Licensure
TX State Medical License 2022 - 2026
OH State Medical License 2013 - 2024
MD State Medical License 2010 - 2013- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 31 citationsComparison of the glucagon-like-peptide-1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: A retrospective studyPriyamvada Singh, Maryam Taufeeq, Todd E. Pesavento, Kenneth Washburn, Debbie Walsh
Diabetes, Obesity & Metabolism. 2020-01-13 - 43 citationsLargest single-centre experience of dulaglutide for management of diabetes mellitus in solid organ transplant recipients.Priyamvada Singh, Todd E. Pesavento, Kenneth Washburn, Debbie Walsh, Shumei Meng
Diabetes, Obesity & Metabolism. 2019-04-01 - 70 citationsAfirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules.Mayumi Endo, Fadi Nabhan, Kyle Porter, Katie Roll, Lawrence A. Shirley
Thyroid. 2019-08-19
Press Mentions
Type 1 Diabetes: The Benefits and Limitations of a Pancreas TransplantNovember 15th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
